Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

RASSF5 Polyclonal Antibody, Cy5.5 Conjugated

Product Specifications

Background

Potential tumor suppressor. Seems to be involved in lymphocyte adhesion by linking RAP1A activation upon T-cell receptor or chemokine stimulation to integrin activation. Isoform 2 stimulates lymphocyte polarization and the patch-like distribution of ITGAL/LFA-1, resulting in an enhanced adhesion to ICAM1. Together with RAP1A may participate in regulation of microtubule growth. The association of isoform 2 with activated RAP1A is required for directional movement of endothelial cells during wound healing. May be involved in regulation of Ras apoptotic function. The RASSF5-STK4/MST1 complex may mediate HRAS and KRAS induced apoptosis.

Synonyms

RAPL; Maxp1; NORE1; NORE1A; NORE1B; RASSF3; Ras association domain-containing protein 5; New ras effector 1; Regulator for cell adhesion and polarization enriched in lymphoid tissues; RASSF5

Gene ID

83593

Swiss Prot

Q8WWW0

Cellular Locus

Cytoplasm

Host

Rabbit

Immunogen

321-418/418

Target

RASSF5

Clonality

Polyclonal

Isotype

IgG

Conjugation

Cy5.5

Source

KLH conjugated synthetic peptide derived from human RASSF5

Applications

IF (IHC-P), IF (IHC-F), IF (ICC)

Purification

Purified by Protein A.

Excitation Emission

675nm/694nm

Concentration

1µg/µl

Dilution

IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)

Buffer

Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.

Modification

Unmodified

Storage Conditions

Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Product Datasheet

https://www.biossantibodies.com/datasheets/bs-11168R-Cy5.5

Gene ID URL

83593

Predicted Cross Reactivity

Human, Mouse, Rat, Dog, Cow, Pig

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

3,3'-Diamino-[1,1'-biphenyl]-4,4'-dicarboxylic acid
OR73796-01 100 mg

3,3'-Diamino-[1,1'-biphenyl]-4,4'-dicarboxylic acid

Ask
View Details
3,3'-Diamino-[1,1'-biphenyl]-4,4'-dicarboxylic acid
OR73796-02 1 g

3,3'-Diamino-[1,1'-biphenyl]-4,4'-dicarboxylic acid

Ask
View Details
3,3'-Diamino-[1,1'-biphenyl]-4,4'-dicarboxylic acid
OR73796-03 5 g

3,3'-Diamino-[1,1'-biphenyl]-4,4'-dicarboxylic acid

Ask
View Details
3,3'-Diamino-[1,1'-biphenyl]-4,4'-dicarboxylic acid
OR73796-04 25 g

3,3'-Diamino-[1,1'-biphenyl]-4,4'-dicarboxylic acid

Ask
View Details
DST Antibody, HRP conjugated
A46586-100UG 100 µg

DST Antibody, HRP conjugated

Ask
View Details
Recombinant Vibrio splendidus Peptide chain release factor 3 (prfC), partial
MBS1101467 Inquire

Recombinant Vibrio splendidus Peptide chain release factor 3 (prfC), partial

Ask
View Details